Literature DB >> 2155403

Codons 262 to 490 from the herpes simplex virus ICP4 gene are sufficient to encode a sequence-specific DNA binding protein.

C L Wu1, K W Wilcox.   

Abstract

The HSV-1 immediate early (IE) protein ICP4 (alpha 4, IE175, Vmw175) is an oligomeric molecule which activates transcription of viral early genes, represses transcription of viral IE genes, and binds to specific sequences in certain viral promoters. The extent to which these functions are interrelated has not been fully established. We have expressed truncated portions of the ICP4 gene in E. coli as trpE fusion proteins. DNA-binding studies with these hybrid proteins revealed that ICP4 residues 262 to 490 are sufficient for sequence-specific DNA-binding. DNA-binding was not detected with polypeptides extending from residue 262 to 464 or from residue 306 to 490. Multiple bands of protein-DNA complexes observed in gel mobility shift assays indicate that residues 262 to 490 may also contribute to the oligomerization of ICP4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155403      PMCID: PMC333458          DOI: 10.1093/nar/18.3.531

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  Separation and characterization of herpes simplex virus type 1 immediate-early mRNA's.

Authors:  R J Watson; C M Preston; J B Clements
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

2.  Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells.

Authors:  L Pereira; M H Wolff; M Fenwick; B Roizman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

3.  Mapping of functional and antigenic domains of the alpha 4 protein of herpes simplex virus 1.

Authors:  J Hubenthal-Voss; R A Houghten; L Pereira; B Roizman
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

5.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

6.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

7.  Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175.

Authors:  R A Dixon; P A Schaffer
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

8.  Anthranilate synthetase, an enzyme specified by the tryptophan operon of Escherichia coli: Comparative studies on the complex and the subunits.

Authors:  J Ito; C Yanofsky
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

9.  Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA.

Authors:  K W Wilcox; A Kohn; E Sklyanskaya; B Roizman
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  Poly(ADP-ribosyl)ation of a herpes simplex virus immediate early polypeptide.

Authors:  C M Preston; E L Notarianni
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

View more
  27 in total

1.  Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription.

Authors:  James W Bruce; Kent W Wilcox
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation.

Authors:  Peter Compel; Neal A DeLuca
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Activities of heterodimers composed of DNA-binding- and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4.

Authors:  A A Shepard; N A DeLuca
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Nucleotides within both proximal and distal parts of the consensus sequence are important for specific DNA recognition by the herpes simplex virus regulatory protein ICP4.

Authors:  L I Pizer; R D Everett; D G Tedder; M Elliott; B Litman
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

5.  A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties.

Authors:  A A Shepard; N A DeLuca
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells.

Authors:  P Cheung; B Panning; J R Smiley
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27.

Authors:  C A Panagiotidis; E K Lium; S J Silverstein
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

9.  The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters.

Authors:  C L Wu; K W Wilcox
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly.

Authors:  W M Flanagan; A G Papavassiliou; M Rice; L B Hecht; S Silverstein; E K Wagner
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.